POST ACUTE MEDICAL TULSA — History
CCN 372018 | 3-year financial timeline | COVID resilience: 28/100
🛡️ Public data only — no PHI permitted on this instance.
$24M
Latest Revenue (FY2022)
-9.9%
Revenue CAGR (3yr)
11.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $29M | $27M | $24M | -11.9% | -9.9% |
| Operating Expenses | $24M | $23M | $21M | -10.5% | -7.1% |
| Operating Margin | 16.3% | 12.5% | 11.1% | -11.2% | -17.7% |
| Net Income | $5M | $3M | $3M | -21.8% | -25.8% |
| Licensed Beds | 60 | 60 | 60 | +0.0% | +0.0% |
| Total Patient Days | 16,569 | 14,897 | 12,640 | -15.2% | -12.7% |
| Medicare Day % | 66% | 64% | 67% | +4.8% | +0.7% |
| Medicaid Day % | 0% | 2% | 7% | +192.7% | +653.3% |
COVID Impact & Recovery
Resilience Score: 28/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -18.8% ($29M → $24M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-9.9%
This Hospital
+7.6%
State Avg
Latest Margin
11.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $21M | 8.4% |
| FY2024 (proj) | $18M | 5.8% |
| FY2025 (proj) | $15M | 3.2% |